Levodopa Plus Benserazid Al

Levodopa, the active ingredient in Levodopa Plus Benserazid Al, is a Levodopa/benserazide combination presented as an oral tablet for oral use. Classified as an antiparkinson agent and marketed in the EU, it is used to improve motor function in adult patients with Parkinson's disease.

GNH USA supplies Levodopa Plus Benserazid Al as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance for global distribution, including procurement teams in emerging markets and research institutions.

Levodopa/benserazide acts on the dopaminergic pathway to manage Parkinsonian disorders. - Parkinson's disease: improves motor symptoms such as bradykinesia, rigidity and tremor. - Early-stage Parkinsonian syndrome: delays the onset of motor fluctuations. - Advanced Parkinson's disease with motor fluctuations: reduces "off" periods and enhances daily functioning.

Levodopa/benserazide may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Dizziness: often related to orthostatic changes. - Headache: transient and usually resolves. - Insomnia: difficulty initiating sleep. - Orthostatic hypotension: drop in blood pressure upon standing. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Dyskinesia: involuntary, erratic movements. - Hallucinations: visual or auditory disturbances. - Severe hypotension: may lead to fainting. - Cardiac arrhythmias: irregular heart rhythms. - Neuroleptic malignant syndrome: rare but life‑threatening reaction. - Anaphylaxis: acute allergic response requiring emergency care.

Levodopa/benserazide requires careful monitoring to ensure safe use. - Monitor blood pressure: watch for orthostatic drops, especially at treatment initiation. - Assess psychiatric status: be alert for hallucinations or confusion. - Adjust dose in renal impairment: reduced clearance may increase exposure. - Avoid abrupt discontinuation: taper gradually to prevent withdrawal symptoms. - Use with caution in elderly patients: increased sensitivity to side effects. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Levodopa/benserazide can interact with several drug classes.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: risk of hypertensive crisis. - Antipsychotics (dopamine antagonists): may diminish therapeutic effect. - High‑protein meals: can reduce levodopa absorption. - MAO‑B inhibitors: increase risk of serotonin syndrome.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: additive blood‑pressure lowering. - SSRIs and SNRIs: potential for serotonin excess. - Other antiparkinson drugs: may require dose adjustments. - Alcohol: can exacerbate dizziness and hypotension.